Zobrazeno 1 - 10
of 15
pro vyhledávání: '"James D. Finklea"'
Autor:
Jane E. Gross, James D. Finklea, Silvia M. Caceres, Katie R. Poch, Nabeeh A. Hasan, Fan Jia, L. Elaine Epperson, Ettie M. Lipner, Charmie K. Vang, Jennifer R. Honda, Matthew J. Strand, Vinicius Calado Nogueira de Moura, Charles L. Daley, Michael Strong, Jerry A. Nick
Publikováno v:
ERJ Open Research, Vol 10, Iss 4 (2024)
Rationale Nontuberculous mycobacteria (NTM) has been reported to be transmitted between people with cystic fibrosis (CF) attending CF centres. A suspected Mycobacterium abscessus outbreak was investigated at the University of Texas Southwestern (UTSW
Externí odkaz:
https://doaj.org/article/4c1e359a5916408f94be2d9da8823672
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 28, Iss , Pp 67-70 (2022)
ABSTRACT: Objectives: Vancomycin remains a first-line treatment for methicillin-resistant Staphylococcus aureus (MRSA)-mediated acute pulmonary exacerbations (APEs) in adult cystic fibrosis (CF) patients; however, optimal alternatives remain poorly d
Externí odkaz:
https://doaj.org/article/1928b186dc1143ad8ff03fb20ccd6ea5
Autor:
Angela Wang, MinJae Lee, Ashley Keller, Sarah Jian, Karen Lowe, James D. Finklea, Raksha Jain
Publikováno v:
Journal of Cystic Fibrosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fedb0d58f4d6b5fbe4ee278fc6eae1ed
https://doi.org/10.1016/j.jcf.2023.05.009
https://doi.org/10.1016/j.jcf.2023.05.009
End-of-Life Care in Cystic Fibrosis: Comparing Provider Practices Based on Lung Transplant Candidacy
Autor:
Allison Virginia Lange, Stephanie Terauchi, James D. Finklea, Joan S. Reisch, Ali Rueschhoff, Raksha Jain, Leah Cohen
Publikováno v:
Journal of Palliative Medicine. 23:1606-1612
Background: The optimal timing to introduce palliative care (PC) and end-of-life (EOL) conversations into the lives of people with cystic fibrosis (CF) has not been established. Objective: Compare ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5187ec8765562efb7d2960a71bad5001
https://doi.org/10.1089/jpm.2019.0304
https://doi.org/10.1089/jpm.2019.0304
Publikováno v:
Diagnostic microbiology and infectious disease. 99(2)
Pseudomonas aeruginosa is a commonly isolated pathogen in adults with cystic fibrosis (CF). Antimicrobial resistance is an escalating problem due to chronic colonization and frequent antimicrobial exposure. Ceftolozane-tazobactam (C/T) and ceftazidim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a292f7d5c7c8f08ee01e7fcb5184c70d
https://pubmed.ncbi.nlm.nih.gov/33152675
https://pubmed.ncbi.nlm.nih.gov/33152675
Autor:
James D. Finklea, David E. Greenberg, Raksha Jain, Rita Hollaway, Stan D. Atkin, Michael L. Foster, Mariana Castanheira, Helio S. Sader, Shadaan Abid, Ashley Keller, Moumita Bose
Publikováno v:
Infection and Drug Resistance. 11:1499-1510
Purpose Ceftazidime-avibactam is a novel antimicrobial combining a third-generation cephalosporin with a non-β-lactam β-lactamase inhibitor that was recently approved to treat Gram-negative hospital- and ventilator-acquired pneumonia. The use of ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c57eb73fdc4de5127acedc48a1fa3bb4
https://doi.org/10.2147/idr.s173804
https://doi.org/10.2147/idr.s173804
Autor:
James D. Finklea, Fernando Torres, Vaidehi Kaza, Deepa Raghavan, Chul Ahn, Raksha Jain, Ang Gao
Publikováno v:
The Journal of Heart and Lung Transplantation. 35:1487-1496
Background The overall life expectancy of women with cystic fibrosis (CF) is shorter compared with men with CF without accounting for lung transplant recipients. However, it is unclear how donor and recipient gender impact long-term outcomes in patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b64dd0ca61289660cedb9a1a00f581be
https://doi.org/10.1016/j.healun.2016.06.013
https://doi.org/10.1016/j.healun.2016.06.013
Autor:
Stan D, Atkin, Shadaan, Abid, Michael, Foster, Moumita, Bose, Ashley, Keller, Rita, Hollaway, Helio S, Sader, David E, Greenberg, James D, Finklea, Mariana, Castanheira, Raksha, Jain
Publikováno v:
Infection and drug resistance. 11
Ceftazidime-avibactam is a novel antimicrobial combining a third-generation cephalosporin with a non-β-lactam β-lactamase inhibitor that was recently approved to treat Gram-negative hospital- and ventilator-acquired pneumonia. The use of ceftazidim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e1e6eed2e671dc0dd38de1f2957fa7fd
https://pubmed.ncbi.nlm.nih.gov/30271183
https://pubmed.ncbi.nlm.nih.gov/30271183
Publikováno v:
Open Forum Infectious Diseases
Background Pseudomonas aeruginosa is a commonly isolated pathogen in adults with cystic fibrosis (CF). Antimicrobial resistance is an escalating problem due to chronic colonization and frequent antimicrobial exposure. Ceftolozane–tazobactam (C/T) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36a6d0dbb24ecc5842821ca8cea55df0
https://doi.org/10.1093/ofid/ofz360.1458
https://doi.org/10.1093/ofid/ofz360.1458
Publikováno v:
Diagnostic microbiology and infectious disease. 92(1)
Ceftolozane/tazobactam is a combination intravenous antibiotic with potentially important activity against drug-resistant Gram-negative organisms. Ceftolozane/tazobactam's in vitro activity was evaluated in 30 samples collected from 23 adult cystic f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::321f9b0c5e709a4e1c84e9c61f0a2e28
https://pubmed.ncbi.nlm.nih.gov/29884565
https://pubmed.ncbi.nlm.nih.gov/29884565